Conclusions Ultimately, the current maintenance dose of 1,000 mcg B12 every 3 months may confer long term harm, therefore it seems that once B12 levels are stabilised well within acceptable range, then the standard B12 intervention of 1000 mcg should be administered annually, and monitored with pre-injection annual testing of levels
This science-backed method revolves around replenishing a vital anti-aging molecule your body produces naturally: NAD+ (nicotinamide adenine dinucleotide)
While there is no data to establish the safety of 5-amino-1MQ in humans, rodent studies have found no significant adverse effects [1, 6, 11]
Systemic effects of carnitine supplementation: A review of adverse event reports
Tirzepatide drops and tablet formulations represent the future of delivery convenience, though injectable remains the standard for now and delivers the most reliable bioavailability